Evidence map›Paper›PMID 12239314›Full record

ArticleJournal of virology2002

Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells.

Wei Ding, Björn Albrecht, Robert E Kelley, Natarajan Muthusamy, Seung-Jae Kim, Ruth A Altschuld, Michael D Lairmore

Abstract read
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Complete Rescue of HTLV-1Pathogens (Basel, Switzerland) · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wei DingCenter for Retrovirus Research, Department of Veterinary Biosciences, The Ohio State University, 1925 Coffey Road, Columbus, OH 43210, USA.
Björn Albrecht
Robert E Kelley
Natarajan Muthusamy
Seung-Jae Kim
Ruth A Altschuld
Michael D Lairmore

Funding

ANIMAL MODELS OF MOLECULAR PATHOGENSIS OF HTLV-1R01RR014324 · NCRR · OHIO STATE UNIVERSITY · PI LAIRMORE, MICHAEL D · 1999 to 2003
$1.2M
Mechanism of p12I and p30II in HTLV1 InfectionR01CA092009 · NCI · OHIO STATE UNIVERSITY · PI LAIRMORE, MICHAEL D · 2002 to 2003
$309k
CRE-MEDIATED TRANSCRIPTION IN PRIMARY T LYMPHOCYTESK02AI001474 · NIAID · OHIO STATE UNIVERSITY · PI LAIRMORE, MICHAEL D · 1997 to 2001
$200k
NCI NIH HHS CA 92009NCI NIH HHS R01 CA092009NCRR NIH HHS R01 RR014324NCRR NIH HHS RR 14324NIAID NIH HHS AI 01474
6 · The paper itself

Abstract

Human T-cell lymphotropic virus type 1 (HTLV-1) establishes persistent infection and is associated with lymphoproliferative or neurodegenerative diseases. As a complex retrovirus, HTLV-1 contains typical structural and enzymatic genes, as well as regulatory and accessory genes encoded in the pX region. The early events necessary for HTLV-1 to establish infection in lymphocytes, its primary target cells, remain unresolved. Recent studies have demonstrated the importance of regulatory and accessory gene products in determining this virus-host interaction. Among these, pX open reading frame I, which encodes two proteins, p12(I) and p27(I), is required for establishing persistent infection in vivo and for infection in quiescent primary lymphocytes. In addition, p12(I) localizes in the endoplasmic reticulum (ER) and cis-Golgi apparatus and associates with a calcium binding protein, calreticulin. We recently reported that p12(I) expression induces the calcium-responsive T-cell transcription factor, nuclear factor of activated T cells (NFAT), in the presence of phorbol ester activation. Based on these studies, we hypothesize that p12(I) may modulate calcium release from the ER. Here, we report that p12(I) expression increases basal cytoplasmic calcium and concurrently diminishes calcium available for release from the ER stores. Overexpression of calreticulin, a calcium buffer protein, blocked p12(I)-mediated NFAT activation independently of its ability to bind p12(I). Chemical inhibition studies using inhibitors of inositol 1,4,5-triphosphate receptor and calcium release-activated calcium channels suggest that inositol 1,4,5-triphosphate receptor in the ER membrane and calcium release-activated calcium channels in the plasma membrane contribute to p12(I)-mediated NFAT activation. Collectively, our results are the first to demonstrate the role of p12(I) in elevating cytoplasmic calcium, an antecedent to T-cell activation, and further support the important role of this accessory protein in the early events of HTLV-1 infection.

Indexed as

Nuclear ProteinsCalciumCalcium-Binding ProteinsCalcium ChannelsCalreticulinCytoplasmDeltaretrovirus AntigensDNA-Binding ProteinsEndoplasmic ReticulumGene ExpressionHeLa CellsHumansHuman T-lymphotropic virus 1Inositol 1,4,5-Trisphosphate ReceptorsJurkat CellsLymphocyte ActivationCalciumCalcium-Binding ProteinsCalcium ChannelsCalreticulinDeltaretrovirus AntigensDNA-Binding ProteinsInositol 1,4,5-Trisphosphate ReceptorsITPR1 protein, humanNFATC Transcription FactorsNuclear ProteinsOncogene Proteins, Viralp12I protein, Human T-lymphotropic virus 1Receptors, Cytoplasmic and NuclearRibonucleoproteinsTranscription FactorsViral Regulatory and Accessory Proteins

Identifiers

PMID12239314
PMCPMC136546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.